Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival (2023)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1016/j.htct.2022.05.003
- Subjects: ESTUDOS DE COORTES; COVID-19; PACIENTES INTERNADOS; DOENÇAS HEMATOLÓGICAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Hematology transfusion and cell therapy
- ISSN: 2531-1379
- Volume/Número/Paginação/Ano: v. 45, n. 3, p. 306-316, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FAUCHEUX, Lilith et al. Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival. Hematology transfusion and cell therapy, v. 45, n. 3, p. 306-316, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57327. Acesso em: 06 fev. 2026. -
APA
Faucheux, L., Alves, L. B. de O., Chevret, S., & Rocha, V. G. (2023). Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival. Hematology transfusion and cell therapy, 45( 3), 306-316. doi:10.1016/j.htct.2022.05.003 -
NLM
Faucheux L, Alves LB de O, Chevret S, Rocha VG. Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival [Internet]. Hematology transfusion and cell therapy. 2023 ; 45( 3): 306-316.[citado 2026 fev. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57327 -
Vancouver
Faucheux L, Alves LB de O, Chevret S, Rocha VG. Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival [Internet]. Hematology transfusion and cell therapy. 2023 ; 45( 3): 306-316.[citado 2026 fev. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57327 - Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
- Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases
- A novel mutation in RHAG causing Rh-null phenotype in Colombia. [Editorial]
- Comparative analysis of the variability of the human leukocyte antigen peptide-binding pockets in patients with acute leukaemia
- Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan
- Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
- Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era
- Validation of a formula predictive of peripheral blood stem cell yield and successful collection in healthy allogeneic donors
- Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease [Carta]
- Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin
Informações sobre o DOI: 10.1016/j.htct.2022.05.003 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
